Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphoma

The prognosis of patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) remains unsatisfactory and, despite major advances in genomic studies, the biological mechanisms underlying chemoresistance are still poorly understood. We conducted for the first time a large-scale differ...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Sci Rep
Auteurs principaux: Fornecker, Luc-Matthieu, Muller, Leslie, Bertrand, Frédéric, Paul, Nicodème, Pichot, Angélique, Herbrecht, Raoul, Chenard, Marie-Pierre, Mauvieux, Laurent, Vallat, Laurent, Bahram, Seiamak, Cianférani, Sarah, Carapito, Raphaël, Carapito, Christine
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group UK 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6351558/
https://ncbi.nlm.nih.gov/pubmed/30696890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-37273-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires